Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).

Clinical trial NCT05161702 · RECRUITING

Trial details

NCT number: NCT05161702
Sponsor: SCF Pharma
Status: RECRUITING
Study type: OBSERVATIONAL

Resolution of Inflammation Reduction of Cell Proliferation

Start date: 2019-03-12
Primary completion: 2026-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.